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Background:  Current guidelines recommend statins in children aged ≥ 10 years if low density lipoprotein cholesterol (LDL C) ≥ 190 mg/dl or, if 
lower with other risks. Objective: Do current guidelines select & impact children with the highest vascular risk? 
Methods:  Modifiable risk factors - BMI Z score, Systolic blood pressure (SBP), LDL C, Triglyceride (TG), High density lipoprotein cholesterol (HDL C), 
Insulin, Tobacco smoke exposure & carotid artery intima-media thickness (CIMT) of 41 children (23 obese & 18 non-obese) who were statin eligible 
or non-eligible were compared. 
Results:  Age at Visit 1 (V1) - Obese 11.5 ± 3.0 yrs, Non-obese 14.1 ± 3.1 yrs (p<0.01). Sex, race, tobacco smoke exposure history, & SBP were 
comparable. LDL C, HDL C & TG trends are illustrated (figure). Hyperinsulinemia, noted in a third of the obese group only, did not change over time. 
Risk factors # - (V1, V2 - Visit 2) - Obese 3.6 ± 1.1, 3.8 ± 1.2 Non-obese 1.6 ± 1.1, 1.7 ± 1.1 (p<0.01). CIMT (mm) - (V1, V2) - Obese 0.57 ± 0.05, 
0.57 ± 0.05 Non- obese 0.57 ± 0.06, 0.57 ± 0.06 (p=ns). Obese children had decreasing risk for obesity (OR=0.16) & Non-obese children had an 
increasing risk for obesity over time (OR=6.5). 
Conclusions:  Obese children were younger with higher number of risk factors & CIMT comparable to non-obese, with no improvements noted with 
interventions. The emergence of obesity in Non-obese may have impacted their vascular response to statins. There is substantial residual vascular 
risk in high risk children following interventions. 
